Granules India Limited, a vertically integrated Indian pharmaceutical company, announced today that its wholly-owned foreign subsidiary, Granules Pharmaceuticals, Inc. (GPI), has received final approval from the U.S. Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Lisdexamfetamine Dimesylate Capsules in strengths
The gummies are formulated to cater to the specific needs of growing children. Health OK’, a multivitamin and minerals tablet from the house of Mankind Pharma has expanded its product offering with the launch of Gummies for Children under the age group of 7-17 years old.
Join 2M+ industry professionals with MedgateToday - curated insights, delivered daily.
